Skip to content
Review Open access

Pleiotropic regulation of KDM6B in macrophage-associated physiological and pathological processes.

Aug 2026 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · Vol 203, pp. 119893 · 0 citations · 139 references
Medicine

TL;DR

KDM6B-mediated regulation of macrophages is highly dependent on the microenvironment, conferring both promising therapeutic potential and practical challenges, and further elucidation of its precise regulatory circuits in distinct pathological microenvironments will be essential for the development of targeted therapeutic strategies.

Abstract

As central mediators bridging innate and adaptive immunity, macrophages exhibit functional plasticity that is precisely governed by dynamic epigenetic networks, The histone H3K27 demethylase KDM6B acts as a key epigenetic hub that mediates the epigenetic remodeling of macrophages in response to environmental signals and exerts pleiotropic regulatory roles across diverse pathophysiological contexts. In the tumor microenvironment, KDM6B drives the polarization of tumor-associated macrophages toward an M2-like immunosuppressive phenotype, reshapes cellular metabolism, and consequently promotes tumor immune escape and progression. Similarly, in inflammatory and autoimmune diseases, KDM6B acts as a core epigenetic regulator of the NF-κB pathway, initiating and sustaining chronic inflammation by modulating inflammasome activity and accelerating cytokine release. In fibrotic diseases, KDM6B facilitates macrophage M2 polarization and their transdifferentiation into myofibroblasts, positioning itself as a central driver of organ fibrosis initiation and progression. In infectious diseases, KDM6B plays a dual role: it enhances antiviral immune responses to strengthen host defense, yet can also be hijacked by pathogens such as Leishmania donovani and mycobacteria, which induce an immunosuppressive phenotype in macrophages that facilitates pathogen survival. Beyond these contexts, KDM6B also regulates the function of tissue-resident macrophage subsets including microglia, thereby participating in pathophysiological processes such as neuroinflammation and maternal-fetal tolerance. Collectively, KDM6B-mediated regulation of macrophages is highly dependent on the microenvironment, conferring both promising therapeutic potential and practical challenges. Further elucidation of its precise regulatory circuits in distinct pathological microenvironments will be essential for the development of targeted therapeutic strategies.

Read PDF

Similar papers

Review Sep 2026

Inflammasome-autophagy crosstalk in the tumor microenvironment.

This review integrates traditionally studied pathways into a unified NLRP3-autophagy-mitochondrial stress axis and examines how its stage-, cell-, and context-dependent regulation determines tumor fate.

Pratyasha Mahadani, Sushmita Patra, B. S. Patro et al. · 0 citations
Review Open access Jan 2026

TREM2: A Potential Target for the Targeted Therapy of Metabolic Diseases

This review systematically summarize recent advances in understanding the roles of TREM2 in major metabolic diseases, including atherosclerosis, diabetes mellitus and its complications, obesity, and non‐alcoholic steatohepatitis, while highlighting its functional heterogeneity across different diseases contexts.

Ya-Ling Li, Sheng-Quan Liu, C. Chu et al. · 0 citations
Review Open access Sep 2026

Molecular mechanisms of macrophage migration inhibitory factor in related diseases (Review).

Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that exerts dual-faced, context-dependent roles in physiological and pathological processes. While it maintains tissue homeostasis and facilitates repair under normal conditions, MIF acts as a 'double-edged sword' following tissue injury. As a prima...

Li-Ping Chen, Xin-Yi Kang, Xue-Qin Zou et al. · 0 citations
Review Oct 2026

Investigation of Wnt2's Role in Macrophage Polarization and Its Effects on Sepsis.

OBJECTIVE Sepsis, characterized by organ dysfunction from an uncontrolled immune response to infection, remains a leading cause of mortality in critical care settings. A key underlying mechanism involves the imbalance between pro-inflammatory M1-type macrophages and anti-inflammatory M2-type macrophages in the biphasic...

Yan-Fang He, Jian-Fen Sun, Wen-Kai Xiao et al. · 0 citations
Open access Sep 2026

Myeloid STING-ZBP1 Axis Drives Atherosclerosis by Inducing Macrophage PANoptosis

Atherosclerosis is a chronic inflammatory disease in which dysregulated programmed cell death (PCD) critically contributes to plaque progression and instability. PANoptosis, an integrated inflammatory cell death pathway encompassing apoptosis, pyroptosis, and necroptosis, has recently emerged as a key regulator of...

Hong Zhou, Yue-Qing Han, Danmei Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.